GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » Cyclically Adjusted PB Ratio

Alterity Therapeutics (Alterity Therapeutics) Cyclically Adjusted PB Ratio : (As of Apr. 28, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alterity Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Alterity Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics Cyclically Adjusted PB Ratio Chart

Alterity Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.39 0.60 0.31 0.17

Alterity Therapeutics Quarterly Data
Dec17 Jun18 Dec18 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 - 0.17 - -

Competitive Comparison of Alterity Therapeutics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Alterity Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alterity Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's Cyclically Adjusted PB Ratio falls into.



Alterity Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Alterity Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Alterity Therapeutics's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=0/125.6559*125.6559
=0.000

Current CPI (Sep. 2023) = 125.6559.

Alterity Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
200803 0.000 83.864 0.000
200806 27.910 85.071 41.225
200812 12.291 85.814 17.998
200906 8.909 86.278 12.975
200912 17.690 87.578 25.381
201006 11.446 88.971 16.165
201012 6.274 89.993 8.760
201106 16.037 92.129 21.873
201112 11.725 92.686 15.896
201206 11.310 93.244 15.241
201212 17.437 94.730 23.130
201306 20.748 95.473 27.307
201312 25.594 97.330 33.043
201406 43.328 98.352 55.357
201412 36.993 99.002 46.953
201506 33.917 99.838 42.688
201509 0.000 100.302 0.000
201512 29.514 100.673 36.838
201606 26.093 100.859 32.508
201612 22.759 102.159 27.994
201706 20.139 102.809 24.614
201712 17.283 104.110 20.860
201806 13.548 104.945 16.222
201812 8.749 105.967 10.375
201906 8.013 106.617 9.444
201909 0.000 107.174 0.000
201912 5.303 107.917 6.175
202006 2.854 106.246 3.375
202012 7.643 108.846 8.823
202103 0.000 109.496 0.000
202106 6.707 110.332 7.639
202109 0.000 111.168 0.000
202112 7.334 112.654 8.180
202203 0.000 115.069 0.000
202206 6.214 117.112 6.667
202209 0.000 119.248 0.000
202212 4.709 121.477 4.871
202303 0.000 123.148 0.000
202306 3.765 124.170 3.810
202309 0.000 125.656 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Alterity Therapeutics  (NAS:ATHE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Alterity Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Alterity Therapeutics (Alterity Therapeutics) Business Description

Traded in Other Exchanges
Address
350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.